Prophylactic versus Preemptive modified donor lymphocyte infusion for high-risk acute leukemia after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study
出版年份 2023 全文链接
标题
Prophylactic versus Preemptive modified donor lymphocyte infusion for high-risk acute leukemia after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study
作者
关键词
-
出版物
BONE MARROW TRANSPLANTATION
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-01
DOI
10.1038/s41409-023-02137-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial
- (2023) Li Xuan et al. Lancet Haematology
- Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC
- (2022) Paul Chauvet et al. BONE MARROW TRANSPLANTATION
- Defining the Role of Donor Lymphocyte Infusion in High-Risk Hematologic Malignancies
- (2021) Christoph Schmid et al. JOURNAL OF CLINICAL ONCOLOGY
- Pre-emptive use of Sorafenib combined with DLI post HSCT in AML FLT3+: a single center experience
- (2021) Antonella Bruzzese et al. BONE MARROW TRANSPLANTATION
- Mixed T cell lineage chimerism in acute leukemia/MDS using pre-emptive donor lymphocyte infusion strategy—Is it prognostic?—a single-center retrospective study
- (2021) Vipul Sheth et al. Blood Cancer Journal
- Clonal expansion of CD8+ T cells reflects graft-versus-leukemia activity and precedes durable remission following DLI
- (2021) Christian R Schultze-Florey et al. Blood Advances
- Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation
- (2021) Peng Zhao et al. ANNALS OF HEMATOLOGY
- Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS)
- (2021) Xavier Poiré et al. BONE MARROW TRANSPLANTATION
- Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia
- (2021) Christoph Schmid et al. BONE MARROW TRANSPLANTATION
- Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy
- (2021) Pavan Bachireddy et al. Cell Reports
- Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)
- (2020) Andreas Burchert et al. JOURNAL OF CLINICAL ONCOLOGY
- Prophylactic modified donor lymphocyte infusion after low-dose ATG-F-based haploidentical HSCT with myeloablative conditioning in high-risk acute leukemia: a matched-pair analysis
- (2020) Luxin Yang et al. BONE MARROW TRANSPLANTATION
- PD1 inhibitor in combination with 5-azacytidine and low-dose DLI for the successful treatment of AML patients who relapsed after transplantation
- (2020) Chong-Sheng Qian et al. BONE MARROW TRANSPLANTATION
- Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial
- (2020) Lei Gao et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
- (2019) Thierry Guillaume et al. BONE MARROW TRANSPLANTATION
- Managing post allograft relapse of myeloid neoplasms: azacitidine and donor lymphocyte infusions as salvage therapy
- (2019) John Claiborne et al. LEUKEMIA & LYMPHOMA
- Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the acute leukemia working party of the EBMT
- (2019) Bhagirathbhai Dholaria et al. HAEMATOLOGICA
- Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research
- (2019) Aleksandr Lazaryan et al. HAEMATOLOGICA
- Reversal of T Cell Exhaustion by the First Donor Lymphocyte Infusion Is Associated with the Persistently Effective Antileukemic Responses in Patients with Relapsed AML after Allo-HSCT
- (2018) Long Liu et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Epidemiology and biology of relapse after stem cell transplantation
- (2018) Mary Horowitz et al. BONE MARROW TRANSPLANTATION
- Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies
- (2018) Xiao-Ning Gao et al. ANNALS OF HEMATOLOGY
- Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies: a retrospective bicentric analysis of serial infusions of increasing doses of CD3+ cells
- (2018) Raphael Cauchois et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT
- (2018) Christoph Schmid et al. BRITISH JOURNAL OF HAEMATOLOGY
- Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation with Myeloablative Conditioning and Early Prophylactic Granulocyte Colony-Stimulating Factor–Mobilized Donor Lymphocyte Infusions
- (2016) Sarita Rani Jaiswal et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the
- (2016) Sebastian Giebel et al. CANCER
- T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT
- (2014) Y. Luo et al. BLOOD
- Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and a
- (2013) Chen-Hua Yan et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)
- (2012) O. C. Goodyear et al. BLOOD
- Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation
- (2012) C.-H. Yan et al. BLOOD
- Prevention of relapse using DLI can increase survival following HLA-identical transplantation in patients with advanced-stage acute leukemia: a multi-center study
- (2012) Yu Wang et al. CLINICAL TRANSPLANTATION
- The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells
- (2009) C Flotho et al. LEUKEMIA
- Modified Donor Lymphocyte Infusion (DLI) for the Prophylaxis of Leukemia Relapse after Hematopoietic Stem Cell Transplantation in Patients with Advanced Leukemia—Feasibility and Safety Study
- (2008) Xiao-Jun Huang et al. JOURNAL OF CLINICAL IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now